BiotechTube
Native Antigen Company

Native Antigen Company

Oxford, United Kingdom· Est.
thenativeantigencompany.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40.5M

Overview

The Native Antigen Company, founded in 2012 and based in Oxford, UK, is a leading provider of premium infectious disease reagents, including antigens and antibodies. It operates a hybrid business model, selling catalog products and offering extensive contract development and manufacturing services (CDMO) for diagnostic and vaccine R&D. Owned by LGC Clinical Diagnostics, the company's core strength lies in its proprietary VirtuE™ expression platform, which produces accurately folded and glycosylated proteins essential for advanced research and assay development.

Infectious Disease

Technology Platform

Proprietary VirtuE™ expression system for producing native-like recombinant proteins with correct folding and glycosylation, utilizing various cell expression systems.

Funding History

2
Total raised:$40.5M
Series B$28M
Series A$12.5M

Opportunities

Significant growth is driven by global pandemic preparedness efforts, the continuous need for new diagnostic assays, and the trend toward outsourcing R&D by biopharma and diagnostic companies.
Expansion into veterinary pathogens and non-infectious disease markers presents new, diversified revenue streams.

Risk Factors

Risks include competition from larger reagent suppliers, dependency on the infectious disease research funding cycle, and the technical challenge of consistently producing complex, native-like proteins.
Regulatory and quality control demands for supplying the IVD market also pose an ongoing operational risk.

Competitive Landscape

The company competes with large, diversified life science reagent suppliers (e.g., Thermo Fisher, Merck) and specialized antigen/antibody manufacturers (e.g., Sino Biological, ProSci). Its differentiation lies in its focus on native-like protein production, deep infectious disease expertise, and flexible contract service offerings within the LGC network.

More companies in United Kingdom →